| MODULE NAME: | Opioid deprescribing and withdrawal management |
|---|
| MODULE CODE: | L3.3 - 3 |
|---|
| COURSE NAME: | PRESCRIBER AND DISPENSER TRAINING |
|---|
| LEARNING LEVEL: | Level 3 - AOD Treatment Specific Practice |
|---|
| TARGET AUDIENCE: | All prescribers and dispensers. |
|---|
| MODULE TYPE: | Elective |
|---|
| MODULE AIM: | This module provides participants with the theoretical understanding of the place of opioids in therapy and the opioid deprescribing process including pharmacotherapies to assist with discontinuation symptoms. |
|---|
| LEARNING OUTCOMES: | By the end of this module, learners will be able to: - Identify the place of opioids in therapy.
- Determine the risk benefit ratio in continued prescribing / dispensing.
- Construct a patient-centred tapering plan through prioritising patient agreement and effective collaboration.
- Identify and recommend specific pharmacotherapies and strategies to treat symptoms of medication discontinuation and withdrawal.
- Evaluate patient progress and apply pharmaceutical knowledge in adjusting the tapering plan during an opioid discontinuation.
|
|---|
| LENGTH: | 1.5 hours |
|---|
| CPD: | This module is accredited for: - 1.0 hours of Educational Activities and 0.5 hours of Reviewing Performance with RACGP;
- 1.5 hours of CPD with ACRRM; and
- 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities with APC.
Please refer to your Statement of Completion for full details. NB: Insight uploads CPD hours quarterly to ACRRM and RACGP. |
|---|
| REFERENCE LIST: | Available here |
|---|
| LAST UPDATED: | February 2023 |
|---|